Ruple, while in the care of New York City's renowned Memorial Sloan Kettering Cancer Center, swallowed the first three ...

With the FDA approval of retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, researchers are now focusing on resistance mechanisms and future therapies, ...